Valvular & structural heart disease

Design and rationale of the evaluation of transcatheter aortic valve replacement compared to surveillance for patients with asymptomatic severe aortic stenosis: The EARLY transcatheter aortic valve replacement (TAVR) trial

Am Heart JPublished Design and rationale of a randomised controlled trial

Study context

Population
Asymptomatic severe aortic stenosis (AS) with preserved LVEFplanned
Participants
900 participants
Planned comparison
TAVR vs clinical surveillance
Primary endpoint
Death, stroke or unplanned CV hospitalization
Methodological detailsprospective, multicentre, event-based design, 1:1 randomisation, stratified by ability to perform treadmill stress test, Asymptomatic patients with a positive stress test followed in a registry and undergo AVR per guidelines
  • Prospective
  • Multicentre
  • Event-based design
  • 1:1 randomisation
  • Stratified by ability to perform treadmill stress test
  • Asymptomatic patients with a positive stress test followed in a registry and undergo AVR per guidelines

No results yet. This paper sets out the design of a trial; its results are to come.

Original publication

Design and rationale of the evaluation of transcatheter aortic valve replacement compared to surveillance for patients with asymptomatic severe aortic stenosis: The EARLY TAVR trial. Am Heart J. Published 4 December 2023. doi:10.1016/j.ahj.2023.11.019

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.